mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
-0.072 |
0.7 |